Anqa Management’s Frazier Lifesciences Acquisition Corp Unit FLACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-5,815
Closed -$59K – 25
2022
Q3
$59K Hold
5,815
– – 0.06% 26
2022
Q2
$57K Hold
5,815
– – 0.06% 27
2022
Q1
$58K Hold
5,815
– – 0.07% 24
2021
Q4
$58K Hold
5,815
– – 0.07% 22
2021
Q3
$58K Hold
5,815
– – 0.06% 22
2021
Q2
$58K Hold
5,815
– – 0.06% 22
2021
Q1
$59K Buy
+5,815
New +$62K 0.07% 23

Anqa Management's FLACU Position: Q4 2022 in Review

Anqa Management sold out of Frazier Lifesciences Acquisition Corp Unit (FLACU) in Q4 2022, closing a stake of 5,815 shares — an estimated $59K sold.

Anqa Management first reported a position in FLACU in Q1 2021 and held it in 7 quarters. The position peaked at $59K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

  • Anqa Management reported no remaining Frazier Lifesciences Acquisition Corp Unit position as of Q4 2022 after selling out during the quarter.
  • Anqa Management sold 5,815 Frazier Lifesciences Acquisition Corp Unit shares in Q4 2022, an estimated $59K.
  • Anqa Management first reported a position in Frazier Lifesciences Acquisition Corp Unit in Q1 2021 and held it in 7 quarters.
  • Anqa Management's Frazier Lifesciences Acquisition Corp Unit position peaked at $59K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corp Unit as of Q4 2022.

Based on Anqa Management's 13F filing for Q4 2022, filed 13 Feb 2023.